Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial.
Publication
, Journal Article
Fudim, M; Wojdyla, DM; Alexander, JH; Goodman, SG; Mehran, R; Windecker, S; Aronson, R; Vinereanu, D; Halvorsen, S; Bahit, MC; Granger, CB; Lopes, RD
Published in: J Am Heart Assoc
December 21, 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Am Heart Assoc
DOI
EISSN
2047-9980
Publication Date
December 21, 2021
Volume
10
Issue
24
Start / End Page
e023143
Location
England
Related Subject Headings
- Treatment Outcome
- Percutaneous Coronary Intervention
- Humans
- Heart Failure
- Fibrinolytic Agents
- Clinical Trials as Topic
- Atrial Fibrillation
- Acute Coronary Syndrome
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Fudim, M., Wojdyla, D. M., Alexander, J. H., Goodman, S. G., Mehran, R., Windecker, S., … Lopes, R. D. (2021). Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial. J Am Heart Assoc, 10(24), e023143. https://doi.org/10.1161/JAHA.121.023143
Fudim, Marat, Daniel M. Wojdyla, John H. Alexander, Shaun G. Goodman, Roxana Mehran, Stephan Windecker, Ronald Aronson, et al. “Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial.” J Am Heart Assoc 10, no. 24 (December 21, 2021): e023143. https://doi.org/10.1161/JAHA.121.023143.
Fudim M, Wojdyla DM, Alexander JH, Goodman SG, Mehran R, Windecker S, et al. Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial. J Am Heart Assoc. 2021 Dec 21;10(24):e023143.
Fudim, Marat, et al. “Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial.” J Am Heart Assoc, vol. 10, no. 24, Dec. 2021, p. e023143. Pubmed, doi:10.1161/JAHA.121.023143.
Fudim M, Wojdyla DM, Alexander JH, Goodman SG, Mehran R, Windecker S, Aronson R, Vinereanu D, Halvorsen S, Bahit MC, Granger CB, Lopes RD. Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial. J Am Heart Assoc. 2021 Dec 21;10(24):e023143.
Published In
J Am Heart Assoc
DOI
EISSN
2047-9980
Publication Date
December 21, 2021
Volume
10
Issue
24
Start / End Page
e023143
Location
England
Related Subject Headings
- Treatment Outcome
- Percutaneous Coronary Intervention
- Humans
- Heart Failure
- Fibrinolytic Agents
- Clinical Trials as Topic
- Atrial Fibrillation
- Acute Coronary Syndrome
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology